Berinert 500U
Biological
CSL Behring
Total Payments
$1.6M
Transactions
954
Doctors
542
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $1.6M | 954 | 542 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.4M | 14 | 90.1% |
| Honoraria | $112,587 | 40 | 7.0% |
| Travel and Lodging | $25,451 | 65 | 1.6% |
| Food and Beverage | $20,095 | 823 | 1.3% |
| Education | $537.74 | 12 | 0.0% |
Payments by Type
Research
$1.4M
14 transactions
General
$158,671
940 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks | CSL Behring | $1.1M | 0 |
| Phase I/II, Double-Blind, Placebo-Controlled Study: Assessing Safety & Efficacy of Preoperative & Post Transplant C1 Inhibitor (Berinert) vs. Placebo | CSL Behring | $237,317 | 0 |
| Use of C1-INH to Prevent HLA 7 Antibody Triggered Endothelial Cell Activation & Antibody Mediated Rejection | CSL Behring | $56,657 | 0 |
| Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients | CSL Behring | $13,800 | 0 |
| In vivo research in animal models of organ transplantation | CSL Behring | $5,630 | 0 |
Top Doctors Receiving Payments for Berinert 500U
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Orange, CA | $1.4M | 14 |
| , M.D | Pediatric Allergy/Immunology | Santa Monica, CA | $31,180 | 37 |
| Ellen Pratt | Allergy & Immunology | Springfield, IL | $24,221 | 33 |
| , M.D | Specialist | Dallas, TX | $20,982 | 20 |
| Maziar Rezvani | — | Atlanta, GA | $15,611 | 23 |
| , MD, PHD | Allergy | Wheaton, MD | $12,006 | 18 |
| , MD | Allergy & Immunology | Los Angeles, CA | $11,613 | 10 |
| , MD | Allergy & Immunology | Scottsdale, AZ | $9,641 | 12 |
| , MD | Allergy & Immunology | Los Angeles, CA | $5,209 | 8 |
| , DO | Allergy & Immunology | Hershey, PA | $4,232 | 7 |
| , MD | Internal Medicine | Cincinnati, OH | $3,804 | 8 |
| , MD | Emergency Medicine | Philadelphia, PA | $3,440 | 1 |
| , MD | Allergy & Immunology | Washington, DC | $374.83 | 10 |
| , MD | Allergy & Immunology | Portland, OR | $237.60 | 5 |
| , MD | Allergy & Immunology | Woodbury, NJ | $171.81 | 4 |
| , MD | Allergy & Immunology | Orange, CA | $153.48 | 7 |
| , M.D | Allergy & Immunology | Chattanooga, TN | $125.34 | 3 |
| Elizabeth Feuille | Pediatric Allergy/Immunology | Bronx, NY | $124.90 | 1 |
| , M.D | Allergy & Immunology | Boston, MA | $124.90 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | New York, NY | $124.90 | 1 |
| , M.D | Allergy & Immunology | Irvine, CA | $119.93 | 2 |
| Stanley Lane | — | Moorestown, NJ | $116.23 | 3 |
| , D.O | Allergy & Immunology | Meadowbrook, PA | $112.79 | 2 |
| , M.D | Internal Medicine | San Diego, CA | $108.99 | 3 |
| , MD | Anesthesiology | Mount Holly, NJ | $102.73 | 2 |
Ad
Manufacturing Companies
- CSL Behring $1.6M
Product Information
- Type Biological
- Total Payments $1.6M
- Total Doctors 542
- Transactions 954
About Berinert 500U
Berinert 500U is a biological associated with $1.6M in payments to 542 healthcare providers, recorded across 954 transactions in the CMS Open Payments database. The primary manufacturer is CSL Behring.
Payment data is available from 2017 to 2017. In 2017, $1.6M was paid across 954 transactions to 542 doctors.
The most common payment nature for Berinert 500U is "Unspecified" ($1.4M, 90.1% of total).
Berinert 500U is associated with 5 research studies, including "Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks" ($1.1M).